Studying the Acceptability and Feasibility of Medical Abortion

Marshall John , “Acceptability of Fertility Regulating Methods: Designing Technology to Fit People, ”Preventive Medicine Vol. 6, 1977, pp. 65–73.

Cleland John G. Hardy Ellen E. and Tauher Eric , Introduction of New Contraceptives into Family Planning Programs, World Health Organization, Geneva, 1990, pp. 13–15; Keller Alan , “Contraceptive Acceptability Research: Utility and Limitations.”Studies in Family Planning Vol. 10, No. 8/9, 1979, pp. 230–237; Rosen Anne-Sofie , “Acceptability of Abortion Methods.”Bailliere's Clinical Obstetrics and Gynecology Vol 4., No. 2, 1990, pp. 375–390.

Cameron J.T. and Baird D.T. , “Early Pregnancy Termination: A Comparison Between Vacuum Aspiration and Medical Abortion Using Prostaglandin (16,16 dimethyl-trans-2-PGE, methyl ester) or the Antiprogestogen RU 486, ”British Journal of Obstetrics and Gynecology Vol. 95, 1988, pp. 271–276; Rosen Anne-Sofie , “Acceptability of Abortion Methods, ”Bailliere's Clinical Obstetrics and Gynecology Vol. 4, No. 2, 1990, pp. 375–390; Rosen Anne-Sofie Nystedt Lars Bygedeman Marc and Lundstrom Viveca , “Acceptability of a Nonsurgical Method to Terminate Very Early Pregnancy in Comparison to Vacuum Aspiration, ”Contraception Vol. 10, No. 12, 1979, pp. 107–117; Urquhart D.R. and Templeton A.A. , “Acceptability of Medical Pregnancy Termination, ”The Lancet Vol. II, p. 106 July 9, 1988; Urquhart D.R. and Templeton A.A. , “Psychiatric Morbidity and Acceptability Following Medical and Surgical Methods of Induced Abortion, ”British Journal of Obstetrics and Gynecology Vol. 98, 1991, pp. 396–399.

Palca Joseph , “The Pill of Choice?” Science Vol. 24, 1989, pp. 1319–1357; “RU 486 in Developing Countries: Questions Remain,” Outlook Vol 9, No. 3, 1991, (Washington, D.C.: The Program for Appropriate Technology in Health).

“Resume des caracteristiques du produit: Mifegyne 200 mg,” 1990 Ministere de la Solidarite, de la Sante et de la Protection Sociale, Paris, France.

Baird David T. Rodger Mary Cameron Iain T. and Roberts Ian , “Prostaglandins and Antigestagens for the Interruption of Early Pregnancy, ”Journal of Reproductive Fertility Supplement 36, 1988, pp. 173–179; Birgerson Lars and Odlind Viveca , “The Antiprogestational Agent RU 486 as an Abortifacient in Early Human Pregnancy: A Comparison of Three Dose Regimens, ”Contraception Vol. 38, No. 4, 1988, pp. 391–400; Bygdeman M. and Swahn M.L. , “Projesterone Receptor Blockage: Effect on Uterine Contractility and Early Pregnancy, ”Contraception Vol. 32, No. 1, 1985, pp. 45–51; Cameron I.T. Michie A.F. and Baird D. T. , “Therapeutic Abortion in Early Pregnancy with Antiprogestogen RU 486 Alone or in Combination with Prostaglandin Analogue (Gemeprost), ”Contraception Vol. 34, No. 5, 1986, pp. 459–468; Dubois Catherine Ulmann André and Baulieu Etienne-Emile , “Contragestion with Late Luteal Administration of RU 486 (Mifepristone), ”Fertility and Sterility Vol. 50, No. 4, 1988, pp. 593–596; Rodger Mary W. and Baird David T. , “Induction of Therapeutic Abortion in Eary Pregnancy with Mifepristone in Combination with Prostaglandin Pessary, ”The Lancet December, 1987, Vol. II, pp. 1415–1422; Rodger Mary W. Cojen Alison F. and Baird David T. , “Induction of Early Abortion with Mifepristone (RU 486) and Two Different Doses of Prostaglandin (Gemeprost), ”Contraception Vol. 39, No. 5, 1989, pp. 597–502; Silvestre Louise , “Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin Analogue: A Large Scale French Experience, ”The New England Journal of Medicine Vol. 332, No. 10, 1990, pp. 645–648; Swahn M.L. Gottlieb C. Green K. and Bgydeman M. , “Oral Administartion of RU 486 and 9-Methylene PGE2 for Termination of Early Pregnancy, ”Contraception Vol. 41, No. 5, 1990, pp. 461–473; Vervest Harry A.M. and Hespels Amy A. , “Preliminary Results with the Antiprogestational Compound RU 486 (mifepristone) for Interruption of Early Pregnancy, ”Fertility and Sterility Vol 44, No. 5, 1985, pp. 627–632.